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We describe a 42-year-old woman with histologically
confirmed lobomycosis, a cutaneous fungal infection rarely
reported outside of Latin America. Our case represents the
first published report of imported human lobomycosis in
Canada and the fifth in an industrialized country.  
C
utaneous fungal infections are rarely reported outside
of Latin America. We document the first case of
imported human lobomycosis in Canada.
The Study
In February 2001, a healthy, 42-year-old, female geolo-
gist from Canada came to her dermatologist with a slowly
growing, 1.5-cm diameter, dusky-red, nontender, plaque-
like lesion surrounded by keloidal scar tissue on the poste-
rior aspect of her right upper arm (Figure 1). It was located
at the site of a scar from a previous excision attempt of a
similar lesion 2 years earlier. The original lesion was first
noticed while the patient was visiting Southeast Asia in
1996, although she did not seek medical attention until
returning to Canada 1 year later. At that time, coccid-
ioidomycosis was diagnosed based on her history of previ-
ous travel to a disease-endemic region and on the presence
of oval, yeast-like organisms in histologic sections.
However, Coccidioides immitis was never cultured from
the lesion, and serologic studies for this fungus were neg-
ative. After the excision in 1997, nothing was noted further
until October 1999, when a small lesion, similar in color to
the original one, reappeared under the scar and gradually
increased in size. The patient had no other skin lesions and
was otherwise asymptomatic.
The patient had spent time doing geologic work in var-
ious tropical regions over a 7-year period. In 1992–1993,
she traveled to the Four Corners region of the United
States as well as to California, northern Mexico, and Costa
Rica. She lived and worked in the jungles of Guyana and
Venezuela for 2 years (1993 and 1994), spending most of
her time around the Cuyuni, Essequibo, and Rupununi
River areas, although she also spent some time in the
Bolivar state of Venezuela. Thereafter, she traveled to
Kazakhstan, Indonesia (Irian Jaya), and the Philippines
(1995 to 1996). During her time in South America, she
lived mainly in rural camps and had extensive exposure to
freshwater, soil, and underground caves. Health problems
encountered during her travels included dengue fever,
amebic dysentery, and intestinal helminthiasis. Of note,
she had never traveled to the African continent.
Her medical history was otherwise unremarkable.
Family history was positive for hypothyroidism. She was a
nonsmoker and a social alcohol drinker. She was on hor-
mone replacement therapy but no other medications and
had no known allergies. Review of systems was unremark-
able. Other than the lesion on her right arm, results of
physical examination were normal.
Biopsied tissue specimens of the lesion were obtained
and submitted for pathologic and microbiologic examina-
tion. The hematoxylin- and eosin-stained tissue sections
showed a diffuse, superficial, and deep granulomatous der-
matitis with multinucleated giant cells. Intracellular and
extracellular unstained fungal cells with thick refractile
walls were seen, giving a “sieve-like” pattern to the gran-
ulomatous inflammation. The fungal cells stained strongly
with periodic acid-Schiff and Grocott methenamine silver
stains (Figure 2); cells were spherical or lemon-shaped,
approximately 10 µm in diameter, and uniform in size.
They were arranged as single cells or in short budding
chains joined by narrow, tubelike bridges. Calcofluor
white stain (Figure 3) of fresh tissue indicated fluorescent,
spherical fungal organisms similarly arranged in chains.
The organisms were not cultivatable. Fungal morphology
was consistent with Loboa loboi. The lesion was complete-
ly excised with no subsequent recurrence. 
Conclusions
Lobomycosis is a chronic granulomatous infection of
the skin and subcutaneous tissues caused by the fungus L.
loboi(1,2). It is characterized by the appearance of slowly
developing (months, years, or decades), keloid-like, ulcer-
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Figure 1. Photomicrograph of keloidal skin lesion on patient’s right
upper arm.ated, or verrucous nodular or plaque-like cutaneous lesions
(1,2), usually at a site of local trauma such as from a cut,
insect bite, animal bite, or ray sting (1–3). Lesions may be
single or multiple and tend to occur on exposed, cooler
areas of the body, particularly the extremities and ears
(1,2,4). Other sites such as the forehead, face, chest, scapu-
la, lumbosacral spine, buttocks, and scrotum have also
been reportedly involved (2–7). Mucous membranes or
internal organs are not involved (2,3). Lesions may be non-
pigmented, hypopigmented, or hyperpigmented and are
usually painless or only slightly pruritic (1,3,4). Little if
any local host inflammatory response and no systemic
symptoms exist (3,4). In some cases, lesions may spread
contiguously or through lymphatic channels, causing cos-
metic disfigurement (2,4,5).  
On histologic examination, the lesions are composed of
dermal granulomas with multinucleated giant cells filled
with spherical or lemon-shaped fungal cells 6–12 µm in
diameter with doubly refractile walls that are commonly
arranged in chains of budding cells connected by thin,
tube-like bridges (1,2,6,8). Loboa loboi has never been
cultivated in vitro (1,2), although it has been successfully
transmitted to armadillos, tortoises, and the footpads of
hamsters and mice under experimental conditions (2,6).  
Natural disease has been described only in humans and
in marine and freshwater dolphins (1,2). Lobomycosis was
first described by the dermatologist Jorge Lobo in 1931
(2,3,4,9). His patient was a 52-year-old man who worked
as a rubber collector in the Amazonas state of Brazil, who
had numerous slowly developing nodular keloidal lesions
in the lumbosacral spine area, from which microorganisms
resembling  Paracoccidioides brasiliensis were observed
on microscopy (2). Lobo suspected that the patient had a
modified form of paracoccidioidomycosis, which he called
keloidal blastomycosis (2). A second human case was
reported in 1938, after which the disease was termed
Lobo’s disease (2). More than 500 human cases have been
reported to date (3), although the disease appears to be
confined to remote tropical areas of South and Central
America, especially in communities along rivers (1–3).
The natural habitat of the fungus is not known but is
believed to be aquatic or associated with soil and
vegetation (2,3). Rubber workers, farmers, miners,
fishermen, and hunters are particularly at risk due to
extensive outdoor exposure (2–4). The condition has been
described in Bolivia, Brazil, Colombia, Costa Rica,
Ecuador, French Guiana, Guyana, Mexico, Panama, Peru,
Suriname, and Venezuela (2–4).  
The first report of nonhuman infection occurred in 1971
in an Atlantic bottle-nosed dolphin from Florida (10). In
1973, a dolphin with Lobo’s disease was described in
Europe along the Atlantic coast of France and Spain (11).
The dolphin’s caretaker, a resident of Holland, later
acquired the disease, the first human case of lobomycosis
reported outside of Latin America (11). Other cases of
lobomycosis in dolphins have been confirmed, including
one in a dolphin off the Texas coast (2,12).  
Cases of imported human lobomycosis have been
described in the United States and elsewhere (6,7,13,14). A
case of lobomycosis involving the chest was recently
described in an Atlanta, Georgia, man who had previously
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Figure 2. Grocott methenamine silver–stained section of skin biop-
sy specimen revealing a short chain of lemon-shaped fungal cells
connected by thin, tubelike bridges. Morphology is consistent with
the appearance of Loboa loboi. Magnification x1,000.
Figure 3. Calcofluor white stain of skin biopsy specimen. A short
chain of lemon-shaped fungal cells is seen in the left-center of the
field. Cells are connected to each other by thin, tubelike structures.
Magnification x400. traveled to Venezuela and was exposed to extremely high
water pressure while walking under Angel Falls (7),
although the first published description of a human case in
the United States appears to be in an immigrant from
Suriname (6). Recently, cases of imported human lobomy-
cosis were reported in France (13) and Germany (14).
Other imported cases in industrialized countries are
believed to occur but may be misdiagnosed due to physi-
cian unfamiliarity with the disease. As far as we are aware,
our report is the first of human lobomycosis in Canada.
The disease was presumably acquired in Guyana or
Venezuela, because her visits to Mexico and Costa Rica
were unlikely to put her at risk for infection.   
Based on our patient’s history, the physical findings,
and the histologic appearance of the skin lesion, the diag-
nosis of lobomycosis was unequivocally made. Although
other fungi may resemble L. loboi microscopically, includ-
ing  P. brasiliensis,  Blastomyces dermatitidis, and
Histoplasma capsulatum var dubiosii (the cause of African
histoplasmosis), none of them form the characteristic
chains of fungal cells of uniform size, 6- to 12-µm in diam-
eter, connected by thin tubelike isthmuses, the hallmark of
lobomycosis (8). Furthermore, unlike L. loboi, the other
fungi can be grown in vitro on routine mycologic media
(2,8). In contrast to L. loboi, the mother cell of P. brasilien-
sis forms multiple buds and remains larger than the daugh-
ter cells, giving the characteristic “ship’s wheel”
appearance (1,15,16). In addition, paracoccidioidomycosis
is a disease of the oronasal mucous membranes and lungs
(1,16). In contrast to B. dermatididis, the fungal cells of L.
loboi do not form broad-based buds (8). Because the
patient had never traveled to Africa, she was not at risk for
African histoplasmosis. Other conditions that may clinical-
ly resemble lobomycosis include keloids, leprosy, leishma-
niasis, chromoblastomycosis, and malignancy (2,4).  
Lobomycosis does not usually affect the general health
of a person. However, unless lesions are removed at an
early stage, the disease persists for life (2). Rarely, squa-
mous cell carcinoma may develop from lobomycotic
lesions (2,17).  
Successful treatment of lobomycosis usually consists of
total surgical excision of the lesion, preferably with wide
margins (1,2,9), although adjunctive medical therapy with
clofazamine or other agents has sometimes been used in
patients with extensive disease, with limited success (2).
However, a German patient with lobomycosis had com-
plete clinical and histopathologic resolution of disease
after a 1-year treatment course of oral clofazamine and
itraconazole (14). One dolphin with Lobo’s disease was
successfully treated with miconzaole (2). Our patient has
remained disease-free for more than 2 years after surgical
excision of her lobomycotic lesion.  
The nomenclature of the fungus has been subject to
ongoing debate, although a new genus, Lacazia, with
Lacazia loboi as the type species, was recently proposed
by Toborda et al. (16) and appears to be taxonomically
valid. The definitive taxonomic status of this fungus awaits
in vitro culture and subsequent molecular studies, although
phylogenetic analysis of 18S small-subunit rDNA mole-
cules indicates that L. loboi is a distinct and novel species
phylogenetically close to but fundamentally different from
P. brasiliensis(15).
In summary, lobomycosis is a slowly progressive,
chronic, fungal infection of the dermis that is rarely seen in
industrialized countries. This disease should be suspected
in patients with single or multiple keloidal skin lesions,
particularly if they have traveled to remote areas of Latin
America.
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